Synlett 2011(8): 1052-1072  
DOI: 10.1055/s-0030-1259947
ACCOUNT
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Trifluoromethylated and gem-Difluoromethylenated Biologically Interesting Compounds from Fluorine-Containing Synthons

Feng-Ling Qing*, Feng Zheng
Key Laboratory of Organofluorine Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Lu, Shanghai 200032, P. R. of China
Fax: +86(21)64166128; e-Mail: flq@mail.sioc.ac.cn;
Weitere Informationen

Publikationsverlauf

Received 8 December 2010
Publikationsdatum:
07. April 2011 (online)

Abstract

A number of fluorinated versatile building blocks (synthons) were developed for the synthesis of trifluoromethylated and gem-difluoromethylenated biologically interesting compounds. Extensive studies have demonstrated that fluorine atoms have profound stereoelectronic effects on neighboring groups, leading to special performance of the fluorine-containing compounds in reactions. It was found that, in comparison with their nonfluorinated counterparts, a C-O bond adjacent to a CF2 group was more stabilized which made it hard to be substituted in a SN2 way; double bond next to fluorinated groups was too electron deficient to participate in ring-closing-metathesis (RCM) reactions, and the carbocation that was strongly destabilized by neighboring CF2 group reacted immediately with nucleophilic molecules to produce unexpected product and so on. Thus improved methodologies were developed to achieve the desired transformations. The conformational analysis of difluorothiouridine suggested that the gem-difluoro atoms governed the overall conformation of the sugar ring and nucleobase. The biological evaluation of the synthetic difluoromethylenated azasugars towards eight glycosidases showed that the CF2 group decreased the pK a of azasugars which enhanced their binding affinity and selectivity to glycosidases.

1 Introduction

2 Synthesis of Trifluoromethylated Building Blocks and their Application for the Preparation of Biologically Interesting Molecules

2.1 Improved FSO2CF2CO2Me/CuI Method for the Synthesis of Trifluoromethylated Retinoid

2.2 Preparation of α-Trifluoromethyl-α,β-Unsaturated Esters for the Synthesis of Trifluoromethylated Nucleosides and Prolines

2.3 Development of Trifluoropropenyl-Containing Synthons for the Preparation of Trifluoromethylated Analogues of Amino Acids, Sugars, and Macrolactones

3 Preparation of Difluoromethylenated Building Blocks and their Application for the Synthesis of Difluoromethylenated Nucleosides, α,β-Uunsaturated-β-lactones and Azasugars

3.1 Novel Route to Difluorohomoallyl Alcohol and its Wide Utility in the Synthesis of Difluoromethylenated Nucleosides

3.2 Construction of Difluoromethylenated Synthons via Silicon-Induced Reformatskii-Claisen Rearrangement and their Application for the Preparation of Difluoromethylenated Nucleosides

3.3 Synthesis of Azanucleosides Bearing Exocyclic CF2H Group Using a Wittig-Type Olefination Approach

3.4 Conformational Analysis of d-2′-Deoxy-2′,2′-difluoro-4′-dihydro-4′-thiouridine

3.5 Synthesis of Difluoromethylenated Six-Membered α,β-­Unsaturated-β-lactones and other Related Compounds

3.6 Synthesis and Biological Evaluation of Difluoromethylen­ated Azasugars

4 Conclusion

    References

  • 1a Pauling L. The Nature of the Chemical Bond   Cornell University Press; Ithaca: 1960. 
  • 1b Bondi A. J. Phys. Chem.  1964,  68:  441 
  • 2 O’Hagan D. Chem. Soc. Rev.  2008,  37:  308 
  • 3a Clader JW. J. Med. Chem.  2003,  47:  1 
  • 3b Smith DH. van de Waterbeemd H. Walker DK. Pharmacokinetics and Metabolism in Drug Design, Methods and Principles in Medicinal Chemistry   Vol. 13:  Wiley-VCH; Weinheim: 2001. 
  • 3c Tsuchiya T. Adv. Carbohydr. Chem. Biochem.  1990,  48:  91 
  • 4a Böhm H.-J. Banner D. Bendels S. Kansy M. Kuhn B. Müller K. Obst-Sander U. Stahl M. ChemBioChem  2004,  5:  637 
  • 4b Müller K. Faeh C. Diederich F. Science  2007,  317:  1881 
  • 5a Guschlbauer W. Jankowski K. Nucleic Acids Res.  1980,  8:  1421 
  • 5b Cheng DM. Kan L.-S. Ts’o POP. Uesugi S. Takatsuka Y. Ikehara M. Biopolymers  1983,  22:  1427 
  • 5c Uesugi S. Kaneyasu T. Imura J. Ikehara M. Cheng DM. Kan L. Ts’o POP. Biopolymers  1983,  22:  1189 
  • 5d Van der Boogaart JE. Kalinichenko EN. Podkopaeva TL. Mikhailopulo IA. Altona C. Eur. J. Biochem.  1994,  221:  759 
  • 5e Barchi JJ. Karki RG. Nicklaus MC. Siddiqui MA. George C. Mikhailopulo IA. Marquez VE. J. Am. Chem. Soc.  2008,  130:  9048 
  • 5f Leroux F. Jeschke P. Schlosser M. Chem. Rev.  2005,  105:  827 
  • 6a Swain C. Rupniak NMJ. Annu. Rep. Med. Chem.  1999,  34:  51 
  • 6b Wermuth CG. Rational Approaches in Drug Design   Prous Science; Barcelona: 2001.  p.3-20  
  • 7 Park BK. Kitteringham NR. O’Neill PM. Annu. Rev. Pharmacol. Toxicol.  2001,  41:  443 
  • 8 Mikami K. Itoh Y. Yamanaka M. Chem. Rev.  2004,  104:  1 
  • 9a Ojima I. McCarthy JR. Welch JT. Biomedical Frontiers of Fluorine Chemistry   ACS; Washington: 1996. 
  • 9b Bégué J.-P. Bonnet-Delpon D. Chimie Bioorganique et Médicinale du Fluor   EDP Sciences, CNRS Publishers; Paris: 2005. 
  • 9c Smart BE. In Organofluorine Chemistry, Principles and Commercial Applications   Banks RE. Smart BE. Tatlow JC. Plenum Press; New York: 1994.  p.Chap. 3 
  • 9d Hiyama T. Organofluorine Compounds, Chemistry and Applications   Springer; Berlin: 2000. 
  • 9e Shimizu M. Hiyama T. Angew. Chem. Int. Ed.  2005,  44:  214 
  • 9f Hagmann WK. J. Med. Chem.  2008,  51:  4359 
  • 9g Purser S. Moore PR. Swallow S. Gouverneur V. Chem. Soc. Rev.  2008,  37:  320 
  • 10 Langlois BR. Billard T. Synthesis  2003,  185 
  • 11 Chen Q.-Y. Wu S.-W. J. Chem. Soc., Chem. Commun.  1989,  705 
  • 12 Qing F.-L. Fan J. Sun H.-B. Yue X.-J. J. Chem. Soc., Perkin Trans. 1  1997,  3053 
  • 13 Boehm MF. Zhang L. Badea BA. White SK. Mais DE. Berger E. Suto CM. Goldman ME. Heyman RA. J. Med. Chem.  1994,  37:  2930 
  • 14 Qing F.-L. Fan J. Bioorg. Med. Chem. Lett.  1997,  7:  2117 
  • 15 Zhang X. Qing F.-L. Yang Y. Yu J. Fu X.-K. Tetrahedron Lett.  2000,  41:  2953 
  • 16 Qing F.-L. Zhang X. Tetrahedron Lett.  2001,  42:  5929 
  • 17 De Clercq E. J. Clin. Virol.  2004,  30:  115 
  • 18a Agrawal S. Zhao Q. Curr. Opin. Chem. Biol.  1998,  2:  519 
  • 18b Li F. Maag H. Alfredson T. J. Pharm. Sci.  2008,  97:  1109 
  • 19a Ternansky RJ. Hertel LW. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications   Filler R. Kobayashi Y. Yagupolski LM. Elsevier; Amsterdam: 1993.  p.23 
  • 19b Pankiewicz KW. Carbohydr. Res.  2000,  327:  87 
  • 19c Meng W.-D. Qing F.-L. Curr. Top. Med. Chem.  2006,  6:  1499 
  • 19d Liu P. Sharon A. Chu CK. J. Fluorine Chem.  2008,  129:  743 
  • 19e Qiu X.-L. Xu X.-H. Qing F.-L. Tetrahedron  2010,  66:  789 
  • 20 Johnson C. Bhumralkar DP. De Clercq E. Nucleosides Nucleotides  1995,  14:  185 
  • 21 Zhang X. Qing F.-L. Yu Y. J. Org. Chem.  2000,  65:  7075 
  • 22 Zhang X. Qing F.-L. J. Org. Chem.  2002,  67:  1016 
  • 23 Qiu X.-l. Qing F.-l. J. Chem. Soc., Perkin Trans. 1  2002,  2052 
  • 24 Jiang Z.-X. Qin Y.-Y. Qing F.-L. J. Org. Chem.  2003,  68:  7544 
  • 25a Bevilacqua PF. Keith DD. Roberts JL. J. Org. Chem.  1984,  49:  1430 
  • 25b Loh T.-P. Li X.-R. Angew. Chem., Int. Ed. Engl.  1997,  36:  980 
  • 25c Loh T.-P. Li X.-R. Eur. J. Org. Chem.  1999,  1893 
  • 25d McBee ET. Pierce OR. Smith DD. J. Am. Chem. Soc.  1954,  76:  3722 
  • 26 Kollonitsch J. Patchett AA. Marburg S. Maycock AL. Perkins LM. Doldouras GA. Duggan DE. Aster SD. Nature (London)  1978,  275:  906 
  • 27 Tsushima T. Kawada K. Ishihara S. Uchida N. Shiratori O. Higaki J. Hirata M. Tetrahedron  1988,  44:  5375 
  • 28 Dubois J. Dugave C. Foures C. Kaminsky M. Tabet JC. Bory S. Gaudry M. Marquet A. Biochemistry  1991,  30:  10506 
  • 29 Yoder NC. Kumar K. Chem. Soc. Rev.  2002,  31:  335 
  • 30a Bilgiçer B. Fichera A. Kumar K. J. Am. Chem. Soc.  2001,  123:  4393 
  • 30b Wang P. Tang Y. Tirrell DA. J. Am. Chem. Soc.  2003,  125:  6900 
  • 30c Qiu X.-L. Meng W.-D. Qing F.-L. Tetrahedron  2004,  60:  6711 
  • 31 Jiang Z.-X. Qing F.-L. J. Org. Chem.  2004,  69:  5486 
  • 32 Wang B.-L. Jiang Z.-X. You Z.-W. Qing F.-L. Tetrahedron  2007,  63:  12671 
  • 33a Takahashi T. Kusaka S.-i. Doi T. Sunazuka T. Omura S. Angew. Chem. Int. Ed.  2003,  42:  5230 
  • 33b Ishihara K. Kawaguchi T. Matsuya Y. Sakurai H. Saiki I. Nemoto H. Eur. J. Org. Chem.  2004,  3973 
  • 33c Matsuya Y. Kawaguchi T. Ishihara K. Ahmed K. Zhao QL. Kondo T. Nemoto H. Org. Lett.  2006,  8:  4609 
  • 34 Wang B.-L. Yu F. Qiu X.-L. Jiang Z.-X. Qing F.-L. J. Fluorine Chem.  2006,  127:  580 
  • 35 Chen Q. Qiu X.-L. Qing F.-L. J. Org. Chem.  2006,  71:  3762 
  • 36 Lu W. Chan TH. J. Org. Chem.  2000,  65:  8589 
  • 37 Bernardi L. Cerè V. Femoni C. Pollicino S. Ricci A. J. Org. Chem.  2003,  68:  3348 
  • 38 Chen Q. Qiu X.-L. Qing F.-L. J. Fluorine Chem.  2007,  128:  1182 
  • 39 Blackburn GM. England DA. Kolkmann F. J. Chem. Soc., Chem. Commun.  1981,  930 
  • 40a Hertel LW. Boder GB. Kroin JS. Rinzel SM. Poore GA. Todd GC. Grindey GB. Cancer Res.  1990,  50:  4417 
  • 40b Noble S. Goa KL. Drugs  1997,  54:  447 
  • 41a Zhang X. Xia H. Dong X. Jin J. Meng W.-D. Qing F.-L. J. Org. Chem.  2003,  68:  9026 
  • 41b Xu X.-H. Qiu X.-L. Zhang X. Qing F.-L. J. Org. Chem.  2006,  71:  2820 
  • 42 Mathé C. Gosselin G. Antiviral Res.  2006,  71:  276 
  • 43 Bio MM. Xu F. Waters M. Williams JM. Savary KA. Cowden CJ. Yang C. Buck E. Song ZJ. Tschaen DM. Volante RP. Reamer RA. Grabowski EJJ.
    J. Org. Chem.  2004,  69:  6257 
  • 44 Yokoyama M. Synthesis  2000,  1637 
  • 45 Zheng F. Zhang X.-H. Qiu X.-L. Zhang X. Qing F.-L. Org. Lett.  2006,  8:  6083 
  • 46a Chang CN. Doong SL. Zhou JH. Beach JW. Jeong LS. Chu CK. Tsai CH. Cheng YC. Liotta D. Schinazi R. J. Biol. Chem.  1992,  267:  13938 
  • 46b Doong SL. Tsai CH. Schinazi RF. Liotta DC. Cheng YC. Proc. Natl. Acad. Sci. U.S.A.  1991,  88:  8495 
  • 47 Grove KL. Guo X. Liu S.-H. Gao Z. Chu CK. Cheng Y.-C. Cancer Res.  1995,  55:  3008 
  • 48 Wu Y.-Y. Zhang X. Meng W.-D. Qing F.-L. Org. Lett.  2004,  6:  3941 
  • 49 Shaw G. Warrener RN. J. Chem. Soc.  1958,  157 
  • 50 Yue X. Qiu X.-L. Qing F.-L. J. Fluorine Chem.  2008,  129:  866 
  • 51 Xu X.-H. Trunkfield AE. Bugg TDH. Qing F.-L. Org. Biomol. Chem.  2008,  6:  157 
  • 52a Dini C. Collette P. Drochon N. Guillot JC. Lemoine G. Mauvais P. Aszodi J. Bioorg. Med. Chem. Lett.  2000,  10:  1839 
  • 52b Takatsuki A. Kawamura K. Okina M. Kodama Y. Ito T. Tamura G. Agric. Biol. Chem.  1977,  41:  2307 
  • 53 Kusaka T. Yamamoto H. Shibata M. Muroi M. Kishi T. Mizuno K. J. Antibiot.  1968,  21:  255 
  • 54 Yaginuma S. Muto N. Tsujino M. Sudate Y. Hayashi M. Otani M. J. Antibiot.  1981,  34:  359 
  • 55a Crimmins MT. Tetrahedron  1998,  54:  9229 
  • 55b Rodrguez JB. Comin MJ. Mini-Rev. Med. Chem.  2003,  3:  95 
  • 55c Ferrero M. Gotor V. Chem. Rev.  2000,  100:  4319 
  • 56 Weller S. Radomski KM. Lou Y. Stein DS. Antimicrob. Agents Chemother.  2000,  44:  2052 
  • 57 Yang Y.-Y. Meng W.-D. Qing F.-L. Org. Lett.  2004,  6:  4257 
  • 58 Greuter H. Lang RW. Romann AJ. Tetrahedron Lett.  1988,  29:  3291 
  • 59 Martín Castro AM. Chem. Rev.  2004,  104:  2939 
  • 60 Yang Y.-Y. Xu J. You Z.-W. Xu X.-h. Qiu X.-L. Qing F.-L. Org. Lett.  2007,  9:  5437 
  • 61 Xu J. Qiu X.-L. Qing F.-L. Beilstein J. Org. Chem.  2008,  4:  No.18 
  • 62 Zheng F. Zhang X. Qing F.-L. Chem. Commun.  2009,  1505 
  • 63a Qiu X.-L. Qing F.-L. Synthesis  2004,  334 
  • 63b Qiu X.-L. Qing F.-L. J. Org. Chem.  2005,  70:  3826 
  • 64 Zheng F. Fu L. Wang R. Qing F.-L. Org. Biomol. Chem.  2010,  8:  163 
  • 65 Davies-Coleman MT. Rivett DEA. Prog. Chem. Org. Nat. Prod.  1989,  55:  1 
  • 66a de Fátima . Kohn LK. de Carvalho JE. Pilli RA. Biorg. Med. Chem.  2006,  14:  622 
  • 66b Buck SB. Hardouin C. Ichikawa S. Soenen DR. Gauss CM. Hwang I. Swingle MR. Bonness KM. Honkanen RE. Boger DL. J. Am. Chem. Soc.  2003,  125:  15694 
  • 66c Kumar P. Naidu SV. J. Org. Chem.  2006,  71:  3935 
  • 67 You Z.-W. Wu Y.-Y. Qing F.-L. Tetrahedron Lett.  2004,  45:  9479 
  • 68 You Z.-W. Zhang X. Qing F.-L. Synthesis  2006,  2535 
  • 69 You Z.-W. Jiang Z.-X. Wang B.-L. Qing F.-L. J. Org. Chem.  2006,  71:  7261 
  • 70 Lin J. Qiu X.-L. Qing F.-L. Beilstein J. Org. Chem.  2010,  6:  No. 37 
  • 71 Xu J. Zhang X. Qiu X.-L. Qing F.-L. Synthesis  2009,  602 
  • 72a Butters TD. Dwek RA. Platt FM. Chem. Rev.  2000,  100:  4683 
  • 72b Sears P. Wong C.-H. Angew. Chem. Int. Ed.  1999,  38:  2300 
  • 73a Fleet GWJ. Shaw AN. Evans SV. Fellows LE. J. Chem. Soc., Chem. Commun.  1985,  841 
  • 73b Compain P. Martin OR. Curr. Top. Med. Chem.  2003,  3:  541 
  • 74a Butters TD. Dwek RA. Platt FM. Curr. Top. Med. Chem.  2003,  3:  561 
  • 74b Butters TD. van den Broek LAGM. Fleet GWJ. Krulle TM. Wormald MR. Dwek RA. Platt FM. Tetrahedron: Asymmetry  2000,  11:  113 
  • 75 Wang R.-W. Qing F.-L. Org. Lett.  2005,  7:  2189 
  • 76 Wang R.-W. Qiu X.-L. Bols M. Ortega-Caballero F. Qing F.-L. J. Med. Chem.  2006,  49:  2989 
  • 77 Li R.-j. Bols M. Rousseau C. Zhang X.-g. Wang R.-w. Qing F.-L. Tetrahedron  2009,  65:  3717